Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study

Nicolas Hoertel(Université Paris Cité), Frédéric Limosin(Inserm), Marina Sánchez‐Rico(Université Paris Cité), Carlos Blanco(National Institute on Drug Abuse), Nathanaël Beeker(Hôpital Cochin), Alexander Carpinteiro(Essen University Hospital), Philip Gorwood(Inserm), Erich Gulbins(University of Duisburg-Essen), Antoine Neuraz(Hôpital Necker-Enfants Malades), Eric J. Lenze(Washington University in St. Louis), Céline Cougoule(Centre National de la Recherche Scientifique), Pierre Meneton(Inserm), Johannes Kornhuber(Friedrich-Alexander-Universität Erlangen-Nürnberg), Angela M. Reiersen(Washington University in St. Louis), Pedro de la Muela(Universidad Complutense de Madrid), Jesús M. Alvarado(Universidad Complutense de Madrid), Raphaël Vernet(Université Paris Cité), Miriam Abellán(Inserm)
Clinical Pharmacology & Therapeutics
June 4, 2021
Cited by 70


Related Papers